Modified Mayo Score indicating remission Week 12 and Week 24 [clinicaltrials_resource:0000b6f1b6b4d159c16e3abcf84587cf]
The proportion of subjects in remission at Weeks 12 and 24 in the VB-201 160mg (80 mg BID) treatment group compared to placebo group.
clinicaltrials_vocabulary:other outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:other-outcome]
Modified Mayo Score indicating remission Week 12 and Week 24 [clinicaltrials_resource:0000b6f1b6b4d159c16e3abcf84587cf]
The proportion of subjects in remission at Weeks 12 and 24 in the VB-201 160mg (80 mg BID) treatment group compared to placebo group.
Bio2RDF identifier
0000b6f1b6b4d159c16e3abcf84587cf
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0000b6f1b6b4d159c16e3abcf84587cf
measure [clinicaltrials_vocabulary:measure]
Modified Mayo Score indicating remission
time frame [clinicaltrials_vocabulary:time-frame]
Week 12 and Week 24
description
The proportion of subjects in ...... oup compared to placebo group.
identifier
clinicaltrials_resource:0000b6f1b6b4d159c16e3abcf84587cf
title
Modified Mayo Score indicating remission Week 12 and Week 24
@en
type
label
Modified Mayo Score indicating ...... 0b6f1b6b4d159c16e3abcf84587cf]
@en